MYELOID TUNING Trademark

Trademark Overview

On Tuesday, July 16, 2019, a trademark application was filed for MYELOID TUNING with the United States Patent and Trademark Office. The USPTO has given the MYELOID TUNING trademark a serial number of 88517594. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 6, 2023. This trademark is owned by PIONYR IMMUNOTHERAPEUTICS, INC.. The MYELOID TUNING trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer
myeloid tuning

General Information

Serial Number88517594
Word MarkMYELOID TUNING
Filing DateTuesday, July 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer
Disclaimer with Predetermined Text"MYELOID"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePIONYR IMMUNOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePIONYR IMMUNOTHERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, March 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022SOU EXTENSION 5 GRANTED
Thursday, July 28, 2022SOU EXTENSION 5 FILED
Tuesday, August 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 27, 2022SOU EXTENSION 4 GRANTED
Thursday, January 27, 2022SOU EXTENSION 4 FILED
Thursday, January 27, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 6, 2021SOU EXTENSION 3 GRANTED
Tuesday, July 6, 2021SOU EXTENSION 3 FILED
Tuesday, July 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 26, 2021SOU EXTENSION 2 GRANTED
Tuesday, January 26, 2021SOU EXTENSION 2 FILED
Tuesday, January 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 24, 2020SOU EXTENSION 1 GRANTED
Friday, July 24, 2020SOU EXTENSION 1 FILED
Friday, July 24, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 28, 2019ASSIGNED TO LIE
Monday, October 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 21, 2019EXAMINER'S AMENDMENT ENTERED
Monday, October 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2019EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, October 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 7, 2019NON-FINAL ACTION E-MAILED
Monday, October 7, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 1, 2019ASSIGNED TO EXAMINER
Tuesday, July 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 19, 2019NEW APPLICATION ENTERED

Related Keywords

tuning myeloid cancer treatment pharmaceuticals